Download Citation on ResearchGate | Hemoglobinuria paroxística nocturna | Paroxysmal nocturnal hemoglobinuria is a rare acquired chronic hemolytic anemia. La hemoglobinuria paroxística nocturna (HPN) es una enfermedad clonal de las células progenitoras hematopoyéticas originada por la mutación adquirida del. TRATAMIENTO DE LA HEMOGLOBINURIA PAROXISTICA NOCTURNA CON GLOBULINA ANTILINFOCITARIA. Revista de Investigacion Clinica, 45(5).

Author: Shaktigis Tule
Country: Nigeria
Language: English (Spanish)
Genre: Video
Published (Last): 23 February 2008
Pages: 418
PDF File Size: 7.95 Mb
ePub File Size: 17.62 Mb
ISBN: 464-3-43385-213-3
Downloads: 23189
Price: Free* [*Free Regsitration Required]
Uploader: Mikami

Paroxysmal nocturnal hemoglobinuria – Wikipedia

The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. There are several groups where screening for PNH should be undertaken. PNH occurs as a result of a defect in the assembling of these glycolipid-protein structures on the surface of blood cells. Because PIGA encodes an enzyme essential for the expression of a host of surface proteins, the PIGA gene provides a highly sensitive system for the study of somatic mutations in hematopoietic cells.

Klin Wochenschr in German. Paroxysmal nocturnal hemoglobinuria, somatic. Comparison of the historical data with pregancies treated with eculizumab documented improved maternal and fetal outcome.

This antibody against terminal complement protein C5 reduced intravascular hemolysis, hemoglobinuria, and the need for transfusion, with an associated improvement in the quality of life. The findings suggested that PNH involves stepwise clonal evolution derived from a singular stem cell clone, similar to that observed in hematopoietic malignancies. This can account for the behavior of the deficiency as a dominant in hemizygous males and in females with the mutant gene on the active X chromosome in a given lymphoblastoid cell line.

The only protective factor found nnocturna, surprisingly, a history of aplastic anemia antedating the diagnosis of PNH.

This page was last edited on 15 Decemberat Paroxysmal nocturnal hemoglobinuria 2. A patient with paroxysmal nocturnal haemoglobinuria in whom granulocyte colony-stimulating factor administration resulted in nkcturna of recurrent enterocolitis and its associated haemolytic attacks.

Other key features of the disease, such as the high incidence of blood clot formationare incompletely understood. Its clinical hallmark, black urine on arising from sleep, is graphic testimony to intravascular hemolysis during the night. British Journal of Haematology. These mutant cells arise side by side with normal elements, noctugna a hematologic mosaic in which the proportion of nocturnw erythrocytes in the blood determines the severity of the disease.


PY – Y1 – N2 – Objective.


Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria. All the patients had clinical disease consistent with PNH hemolytic anemia with some degree of transient or persistent paroxiwtica and also erythrocytes with enhanced sensitivity to complement mediated lysis in vitro, as documented by either the Ham test or the sucrose lysis assay.

AU – Morales-Polanco, M. Information on the molecular defect was not provided. These include patients with unexplained thrombosis who are young, have thrombosis in an nocturja site e.

Antilymphocyte globulin therapy for paroxysmal nocturnal hemoglobinuria

PNH is rare, with an annual rate of cases per million. Lymphoid and complement immunodeficiency D80—D85 Risk factors affecting patients in nocfurna French population diagnosed by a positive Ham test were used in this multivariate analysis.

Expert curators review the literature and organize it to facilitate your work. Somatic mutations in paroxysmal nocturnal hemoglobinuria: In patients with PNH, Hillmen et al. Gomez-Morales, Laura GutierrezG. Yemoglobinuria tests in PNH show changes consistent with intravascular hemolytic anemia: The authors concluded that in PNH patients, conditions exist that favor the occurrence of diverse somatic mutations in blood cells.

Megaloblastic anemia Pernicious anemia.

Paroxysmal nocturnal hemoglobinuria

They found that the drug was safe and well tolerated by the patients. Administration of granulocyte colony-simulating factor resulted in an increased T-cell count, normalization of T-cell function, increased blood levels of helper T cells Th1 and Th2 cytokines, and improvement in the enterocolitis attacks.

Platelet transfusions were given in 16 pregnancies. By using this site, you agree to the Terms of Use and Privacy Policy. To evaluate the effectiveness of antilymphocyte globulin therapy ALG in patients with paroxysmal nocturnal hemoglobinuria PNH. Prior hemoglobinurla eculizumab the median life expectancy of an individual with PNH was approximately 10 hemoglobinuira. The classic sign of PNH is red discoloration of the urine due to the presence of hemoglobin and hemosiderin from the breakdown of red blood cells.


Rosse suggested that a germline mutation hemolgobinuria in defects in this biosynthetic pathway would be lethal. Historically, the sucrose lysis test, in which nocthrna patient’s red blood cells are placed in low-ionic-strength solution and observed for hemolysis, was used for screening. This theory is supported by the fact that these symptoms improve on administration of nitrates or sildenafil Viagrawhich improves the effect of nitric oxide on muscle cells.

Effect paroxisica eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. The affected clone endows all its descendants–red cells, leukocytes including lymphocytesand platelets–with the altered gene. Since the complement cascade attacks the red blood cells within the blood vessels of the circulatory systemthe red blood cell destruction hemolysis is considered an intravascular hemolytic anemia.

Specifically, it has been hypothesized that an autoimmune attack on normal hemoglobiuria cells targets a GPI-linked molecule and therefore preferentially spares the PNH stem cell, which thus has a growth or survival advantage or both in this abnormal environment. Diseases of red blood cells D50—69,74— Clinical and Translational Science. All 4 patients remained transfusion-independent with no thrombotic episodes after mean follow-up of 30 hemoglobijuria.

In the title of a review of PNH, Nishimura et al. A mutation in the PIGA gene was identified in each of the 4.